PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
06 mai 2021 09h30 HE
|
PAVmed Inc.
Four new senior executives will support growth strategy focused on multi-channel EsoGuard commercialization NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ)...